FDA approves expanded MRI labeling for Abbott neurostim
Abbott (NYSE: ABT) announced today that the FDA approved expanded MRI labeling for its Proclaim DRG neurostimulation system.
Source: massdevice.com
Stay updated with breaking news from Timothy Deer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott (NYSE: ABT) announced today that the FDA approved expanded MRI labeling for its Proclaim DRG neurostimulation system.
With this new approval, people with a Proclaim DRG neurostimulation system can soon receive full-body MRI scans
Elon Musk hopes to top his self-driving cars with brain implants that will store your dreams
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
Abbott received FDA approval for the use of its spinal cord stimulation devices (SCS) for certain people with back pain.